Adrien Briaux

BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers

Florence Coussy, Rania El Botty, Sophie Château‐Joubert et al. · Science Translational Medicine · 2020 · 132 citations · Full text

Breast and ovarian cancer predisposition due to de novo BRCA1 and BRCA2 mutations

Lisa Golmard, Capucine Delnatte, Anthony Laugé et al. · Oncogene · 2015 · 55 citations · Full text

Breast Oncology, Ovarian Cancer Predisposition, Medicine +7

Mutational analysis of anal cancers demonstrates frequent PIK3CA mutations associated with poor outcome after salvage abdominoperineal resection

Wulfran Cacheux, Étienne Rouleau, Adrien Briaux et al. · British Journal of Cancer · 2016 · 53 citations · Full text

Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts

Florence Coussy, Marion Lavigne, Leanne de Koning et al. · Theranostics · 2020 · 53 citations · Full text

ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels

Sophie Rondeau, Sophie Vacher, Leanne de Koning et al. · British Journal of Cancer · 2015 · 52 citations · Full text